Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC 2024-04-26 21:00
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers 2024-04-26 21:00
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa 2024-04-26 12:39
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints 2024-04-26 01:25
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor 2024-04-25 22:00
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil 2024-04-25 21:41
On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference 2024-04-25 21:00
Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2023 2024-04-25 18:45
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer 2024-04-25 17:11
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono 2024-04-25 14:00
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST 2024-04-25 09:02
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint 2024-04-24 22:31
Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting 2024-04-24 22:10
Future Health highlights greater access to treatment for Mental Health Month 2024-04-24 22:00
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results 2024-04-24 19:00
Samsung Biologics Reports First Quarter 2024 Financial Results 2024-04-24 14:45
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab) 2024-04-24 09:27
Yeast Fuel, Developed by Chula's Faculty of Science Soon to Expand Its Production for the Aerospace Industry 2024-04-24 00:00
STUDIO PILATES INTERNATIONAL ANNOUNCES 100TH STUDIO, WITH CONTINUED EXPANSION AND MILESTONE OPENING 2024-04-23 21:00
Zepp Health Corporation Files 2023 Annual Report on Form 20-F 2024-04-23 20:20
1 2 3 4 5 762